<?xml version="1.0" encoding="UTF-8"?>
<p>Annexin A5 (ANXA5) was reported in 1994 as a 33 kDa protein that binds 3 different strains of influenza A and one strain of influenza B via a sialic acid-independent mechanism (
 <xref rid="B59" ref-type="bibr">Otto et al., 1994</xref>). It was further shown that ANXA5 aids the entry of influenza viruses into cells, by acting as an alternative receptor for virus entry (
 <xref rid="B59" ref-type="bibr">Otto et al., 1994</xref>; 
 <xref rid="B33" ref-type="bibr">Huang et al., 1996</xref>). Blocking of this receptor by adding external anti-serum to cell cultures inhibited virus replication, further highlighting the importance of ANXA5-mediated virus entry in the enhancement of virus replication (
 <xref rid="B33" ref-type="bibr">Huang et al., 1996</xref>). Influenza A virions express host ANXA5 in its membrane, inhibiting interferon gamma signaling and promoting virus replication (
 <xref rid="B8" ref-type="bibr">Berri et al., 2014</xref>).
</p>
